In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI.
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
In patients with well-controlled cholesterol after a percutaneous coronary intervention, a higher triglyceride glucose index was tied to higher incidence of adverse clinical outcomes.
A new study showed continued high rates of in-hospital mortality in patients with high-risk PE, despite advances in treatment and creation of PE response teams.
The study showed that a new HEART pathway involving high-sensitivity troponin outperformed conventional troponin in ED chest pain evaluations, detecting acute myocardial infarction more effectively.